APONTIS PHARMA GmbH & Co. KG

Industry / private company


Location: Monheim, Germany (DE) DE

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients with Use of Single-Pill Combinations: Results from the START-Study (2023) Schmieder R, Wassmann S, Predel HG, Weisser B, Blettenberg J, Gillessen A, Randerath O, et al. Journal article Single pill treatment in daily practice is associated with improved clinical outcomes and all-cause mortality in cardiovascular diseases: results from the START project (2022) Weisser B, Wilke T, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, et al. Conference contribution Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany (2022) Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, et al. Journal article Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study (2022) Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, et al. Journal article THE SINGLE PILL CONCEPT LEADS TO IMPROVED PERSISTENCE OF MEDICATION, CLINICAL OUTCOMES AND REDUCED ALL-CAUSE MORTALITY IN HYPERTENSIVE PATIENTS - RESULTS FROM THE START PROJECT (2021) Predel HG, Weisser B, Wassmann S, Gillessen A, Blettenberg J, Fournier V, Noetel A, et al. Conference contribution Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis (2020) Predel HG, Weisser B, Wassmann S, Schmieder R, Blettenberg J, Gillessen A, Fournier , et al. Conference contribution Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis (2020) Predel HG, Weisser B, Schmieder R, Wassmann S, Blettenberg J, Gillessen A, Fournier , et al. Conference contribution